150 related articles for article (PubMed ID: 35650563)
1. Significance of tumor heterogeneity of p-Smad2 and c-Met in HER2-positive gastric carcinoma with lymph node metastasis.
Tsujio G; Maruo K; Yamamoto Y; Sera T; Sugimoto A; Kasashima H; Miki Y; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
BMC Cancer; 2022 Jun; 22(1):598. PubMed ID: 35650563
[TBL] [Abstract][Full Text] [Related]
2. Impact of
Tsujio G; Yashiro M; Sakuma T; Aoyama R; Maruo K; Yamamoto Y; Maeda K
Anticancer Res; 2023 Oct; 43(10):4359-4364. PubMed ID: 37772583
[TBL] [Abstract][Full Text] [Related]
3. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
4. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
[TBL] [Abstract][Full Text] [Related]
6. Expression of insulin-like growth factor-2, c-MET, matrix metalloproteinase-7 and MUC-1 in primary lesions and lymph node metastatic lesions of gastric cancer.
Ajisaka H; Fushida S; Yonemura Y; Miwa K
Hepatogastroenterology; 2001; 48(42):1788-92. PubMed ID: 11813625
[TBL] [Abstract][Full Text] [Related]
7. RhoA, Claudin 18, and c-MET in Gastric Cancer: Clinicopathological Characteristics and Prognostic Significance in Curative Resected Patients.
Pereira MA; Ramos MFKP; Dias AR; Cardili L; Ribeiro RRE; de Castria TB; Zilberstein B; Nahas SC; Ribeiro U; de Mello ES
Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076580
[No Abstract] [Full Text] [Related]
8. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-135 inhibits gastric cancer metastasis by targeting SMAD2.
He Y; Wu L; Dai Y; Li J; Liu S
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9436-9444. PubMed ID: 31773690
[TBL] [Abstract][Full Text] [Related]
10. Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma.
Li Y; Chen CQ; He YL; Cai SR; Yang DJ; He WL; Xu JB; Zan WH
J Surg Oncol; 2012 Sep; 106(3):304-10. PubMed ID: 22231933
[TBL] [Abstract][Full Text] [Related]
11. [The prognostic research of expression and relationship between Helicobacter pylori of c-met oncogene correlation with gastric mucosal proliferation].
Zhuang X; Lin S; Zheng J; Wang L; Sun G; Li Y
Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):381-4. PubMed ID: 11798602
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.
Nagatsuma AK; Aizawa M; Kuwata T; Doi T; Ohtsu A; Fujii H; Ochiai A
Gastric Cancer; 2015 Apr; 18(2):227-38. PubMed ID: 24626858
[TBL] [Abstract][Full Text] [Related]
13. Early and late recurrence after gastrectomy for gastric carcinoma. Univariate and multivariate analyses.
Shiraishi N; Inomata M; Osawa N; Yasuda K; Adachi Y; Kitano S
Cancer; 2000 Jul; 89(2):255-61. PubMed ID: 10918153
[TBL] [Abstract][Full Text] [Related]
14. Alterations of APC, c-met, and p53 genes in tumor tissue and serum of patients with gastric cancers.
Wang JY; Hsieh JS; Chen CC; Tzou WS; Cheng TL; Chen FM; Huang TJ; Huang YS; Huang SY; Yang T; Lin SR
J Surg Res; 2004 Aug; 120(2):242-8. PubMed ID: 15234219
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of gut microbiota in patients with gastric cancer by surgery, chemotherapy and lymph node metastasis.
Chen C; Shen J; Du Y; Shi X; Niu Y; Jin G; Liu Y; Shi Y; Lyu J; Lin L
Clin Transl Oncol; 2022 Nov; 24(11):2181-2190. PubMed ID: 35794453
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
17. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.
Ha SY; Lee J; Jang J; Hong JY; Do IG; Park SH; Park JO; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Kang WK; Kim KM
Int J Cancer; 2015 Apr; 136(7):1629-35. PubMed ID: 25157953
[TBL] [Abstract][Full Text] [Related]
18. Screening and clinical significance of lymph node metastasis-related genes within esophagogastric junction adenocarcinoma.
Han R; Chen G; Li M; Peng ZM; Xu L
Cancer Med; 2021 Aug; 10(15):5088-5100. PubMed ID: 34152098
[TBL] [Abstract][Full Text] [Related]
19. Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization.
Choi J; Lee HE; Kim MA; Jang BG; Lee HS; Kim WH
PLoS One; 2014; 9(11):e111658. PubMed ID: 25364819
[TBL] [Abstract][Full Text] [Related]
20. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]